The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria
- PMID: 3075350
- DOI: 10.1016/0035-9203(88)90187-3
The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria
Abstract
30 pairs of patients with complicated Plasmodium falciparum malaria (with anaemia, hyperpyrexia, jaundice or more than 5% of erythrocytes parasitized) were studied. Patients with cerebral signs and symptoms were excluded. One group of patients was treated with oral mefloquine (750 mg) and artemether (600 mg by injection, 200 mg initially and 100 mg every 12 h). The second group of patients was treated with quinine (10 mg/kg orally every 8 h for 7 d). All patients were admitted to hospital for 7 d and examined subsequently on days 14, 21 and 28. All those treated with mefloquine plus artemether survived and their parasite clearance time and fever clearance time were significantly shorter than those of patients receiving quinine. 2 patients treated with quinine died. There was no recrudescence in any patient of either group.
Similar articles
-
The effect of artemether plus mefloquine on Myanmar patients with complicated falciparum malaria.Southeast Asian J Trop Med Public Health. 1992 Sep;23 Suppl 4:117-21. Southeast Asian J Trop Med Public Health. 1992. PMID: 1364856 Clinical Trial.
-
A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria.Trans R Soc Trop Med Hyg. 1987;81(4):559-61. doi: 10.1016/0035-9203(87)90406-8. Trans R Soc Trop Med Hyg. 1987. PMID: 3328342 Clinical Trial.
-
Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.Lancet. 1992 Nov 21;340(8830):1245-8. doi: 10.1016/0140-6736(92)92947-e. Lancet. 1992. PMID: 1359318 Clinical Trial.
-
New answers through chemotherapy?Experientia. 1984 Dec 15;40(12):1351-7. doi: 10.1007/BF01951888. Experientia. 1984. PMID: 6391949 Review. No abstract available.
-
The role of the qinghaosu derivatives in the treatment of severe malaria.Med Trop (Mars). 1998;58(3 Suppl):59-60. Med Trop (Mars). 1998. PMID: 10212901 Review.
Cited by
-
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1993 Mar;45(3):430-75. doi: 10.2165/00003495-199345030-00009. Drugs. 1993. PMID: 7682911 Review.
-
Artemether for severe malaria.Cochrane Database Syst Rev. 2014 Sep 11;2014(9):CD010678. doi: 10.1002/14651858.CD010678.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Jun 18;6:CD010678. doi: 10.1002/14651858.CD010678.pub3. PMID: 25209020 Free PMC article. Updated.
-
Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia.Am J Trop Med Hyg. 2019 Dec;101(6):1204-1211. doi: 10.4269/ajtmh.19-0379. Am J Trop Med Hyg. 2019. PMID: 31642425 Free PMC article. Review.
-
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.Microbiol Rev. 1996 Jun;60(2):301-15. doi: 10.1128/mr.60.2.301-315.1996. Microbiol Rev. 1996. PMID: 8801435 Free PMC article. Review.
-
Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.Bull World Health Organ. 1992;70(6):777-82. Bull World Health Organ. 1992. PMID: 1486675 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical